- Home
- ROLR vs BLRX Comparison
ROLR vs BLRX Comparison
Compare ROLR & BLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROLR
- BLRX
- Stock Information
- Founded
- ROLR 2021
- BLRX 2003
- Country
- ROLR United States
- BLRX Israel
- Employees
- ROLR N/A
- BLRX N/A
- Industry
- ROLR
- BLRX Biotechnology: Pharmaceutical Preparations
- Sector
- ROLR
- BLRX Health Care
- Exchange
- ROLR NYSE
- BLRX Nasdaq
- Market Cap
- ROLR 42.3M
- BLRX 36.0M
- IPO Year
- ROLR 2024
- BLRX 2011
- Fundamental
- Price
- ROLR $5.12
- BLRX $0.48
- Analyst Decision
- ROLR
- BLRX Strong Buy
- Analyst Count
- ROLR 0
- BLRX 2
- Target Price
- ROLR N/A
- BLRX $11.50
- AVG Volume (30 Days)
- ROLR 36.9K
- BLRX 407.5K
- Earning Date
- ROLR 11-23-2024
- BLRX 11-29-2024
- Dividend Yield
- ROLR N/A
- BLRX N/A
- EPS Growth
- ROLR N/A
- BLRX N/A
- EPS
- ROLR N/A
- BLRX N/A
- Revenue
- ROLR $27,070,026.00
- BLRX $17,048,000.00
- Revenue This Year
- ROLR N/A
- BLRX N/A
- Revenue Next Year
- ROLR N/A
- BLRX N/A
- P/E Ratio
- ROLR N/A
- BLRX N/A
- Revenue Growth
- ROLR 46.39
- BLRX N/A
- 52 Week Low
- ROLR $5.00
- BLRX $0.39
- 52 Week High
- ROLR $8.43
- BLRX $1.93
- Technical
- Relative Strength Index (RSI)
- ROLR N/A
- BLRX 53.32
- Support Level
- ROLR N/A
- BLRX $0.40
- Resistance Level
- ROLR N/A
- BLRX $0.46
- Average True Range (ATR)
- ROLR 0.00
- BLRX 0.03
- MACD
- ROLR 0.00
- BLRX 0.01
- Stochastic Oscillator
- ROLR 0.00
- BLRX 94.50
About ROLR HIGH ROLLER TECHNOLOGIES INC
High Roller Technologies Inc is a company which operates through its subsidiaries controls an online gaming operator. They offer a diverse and dynamic real money i Casino entertainment products to players worldwide through our Platform. Through their Platform we provide a large selection of exciting games, personalized experiences and a community, in a safe, secure environment, built on trust and customer service. iGaming, or online casino, offerings typically include the full suite of games available in land-based casinos, such as blackjack, roulette, baccarat, poker and slot machines.
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.